Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Maravai LifeSciences Holdings, Inc. (MRVI)

14.37   0.07 (0.49%) 11-28 16:00
Open: 14.18 Pre. Close: 14.3
High: 14.57 Low: 14.1227
Volume: 1,382,461 Market Cap: 1,890(M)

Technical analysis

as of: 2022-11-28 4:41:38 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 18.51     One year: 20.28
Support: Support1: 13.4    Support2: 11.15
Resistance: Resistance1: 15.85    Resistance2: 17.37
Pivot: 14.46
Moving Average: MA(5): 14.28     MA(20): 14.76
MA(100): 21.57     MA(250): 28.77
MACD: MACD(12,26): -1.1     Signal(9): -1.3
Stochastic oscillator: %K(14,3): 33.9     %D(3): 31.2
RSI: RSI(14): 38.1
52-week: High: 44.24  Low: 13.4
Average Vol(K): 3-Month: 2,140 (K)  10-Days: 1,799 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ MRVI ] has closed above bottom band by 45.3%. Bollinger Bands are 63.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.59 - 14.65 14.65 - 14.7
Low: 13.98 - 14.04 14.04 - 14.1
Close: 14.27 - 14.37 14.37 - 14.46

Company Description

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.

Headline News

Mon, 28 Nov 2022
Analysts give Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) a "Moderate Buy" recommendation. - Best Stocks

Mon, 28 Nov 2022
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Thu, 17 Nov 2022
Stock Traders Buy High Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat

Wed, 16 Nov 2022
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America - Yahoo Finance

Thu, 10 Nov 2022
Select Equity Makes Large Cut to Maravai LifeSciences (MRVI) Position - Nasdaq

Thu, 03 Nov 2022
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript - The Motley Fool

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 132 (M)
Shares Float 98 (M)
% Held by Insiders 0.4 (%)
% Held by Institutions 97.5 (%)
Shares Short 6,270 (K)
Shares Short P.Month 5,100 (K)

Stock Financials

EPS 1.72
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.82
Profit Margin (%) 26.2
Operating Margin (%) 68
Return on Assets (ttm) 18.6
Return on Equity (ttm) 81.8
Qtrly Rev. Growth -6.6
Gross Profit (p.s.) 5
Sales Per Share 6.89
EBITDA (p.s.) 4.91
Qtrly Earnings Growth -23.8
Operating Cash Flow 495 (M)
Levered Free Cash Flow 332 (M)

Stock Valuations

PE Ratio 8.35
PEG Ratio -0.3
Price to Book value 3.75
Price to Sales 2.08
Price to Cash Flow 3.81

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.